SCHEMBL23917219

SCHEMBL23917219

Nc1ncnc2c1c(-c1cc(O)c(F)c(CN=O)c1)cn2C1Cc2ccccc2C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 3/20 0.50
BTK Q06187 3/20 0.50
ABL1 P00519 13/20 0.48
EGFR P00533 12/20 0.48
SRC P12931 11/20 0.48
ABL2 P42684 11/20 0.48
LCK P06239 5/20 0.48
IGF1R P08069 4/20 0.48
JAK2 O60674 3/20 0.48
INSR P06213 3/20 0.48
RET P07949 3/20 0.48
KIT P10721 3/20 0.48
PDGFRA P16234 3/20 0.48
FGFR4 P22455 3/20 0.48
FGFR3 P22607 3/20 0.48
KDR P35968 3/20 0.48
ALK Q9UM73 3/20 0.48
NTRK1 P04629 2/20 0.48
NPM1 P06748 2/20 0.48
CSF1R P07333 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16654148 0.85 PIK3CD (0.67) PIK3CDBTKABL1EGFRSRC
Hydrochloric Acid SCHEMBL23908623 0.85 PIK3CD (0.66) PIK3CDBTKABL1EGFRSRC
SCHEMBL16655504 0.84 PIK3CD (0.55) PIK3CDBTKABL1EGFRSRC
SCHEMBL16654718 0.83 PIK3CD (0.52) PIK3CDBTKABL1EGFRSRC
SCHEMBL16654294 0.81 PIK3CD (0.52) PIK3CDBTKABL1EGFRSRC
SCHEMBL16654722 0.80 PIK3CD (0.61) PIK3CDBTKABL1EGFRSRC
SCHEMBL31060265 0.79 PIK3CD (0.66) PIK3CDBTKABL1EGFRSRC
SCHEMBL16655471 0.79 PIK3CD (0.66) PIK3CDBTKABL1EGFRSRC
SCHEMBL16655527 0.78 PIK3CD (0.55) PIK3CDBTKABL1EGFRSRC
SCHEMBL16655704 0.77 PIK3CD (0.66) PIK3CDBTKABL1EGFRSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317140-A1 Heterocyclic Compounds and Methods of Use MEDIVATION TECHNOLOGIES, INC. (US) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317140-A1 Heterocyclic Compounds and Methods of Use BTK, PIK3CD, PIK3CB PIK3CD 2/4885BTK 1/4885ABL1 62/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.